Focus on Drug Approvals. This week the FDA approved Ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer. Ensartinib is a potent and specific
Focus on Drug Approvals. The FDA has approved Syndax Pharmaceuticals’ Revumenib (SNDX-5613, inhibitor of menin-KMT2A interaction) for relapsed or refractory acute leukemia with lysine methyltransferase 2A
Is coffee good for your brain? N-Eicosanoyl-serotonin (EHT), a novel natural product found in coffee, has been shown to have a protective effect in models of
Focus on Drug Discovery. A biopharmaceutical company called Soligenix is developing the natural product hypericin as a treatment for cutaneous T-cell lymphoma. Hypericin, applied as a
Journal Club. Paul Rosenfeld and coworkers at the University of Toronto recently reported in the journal Viruses that Rocaglamide, a structurally novel natural product, inhibits HIV-1
Postdocs, we appreciate you! And to show our appreciation, Focus Biomolecules is offering 20% off our products. Click here to get the discount code.
For Postdoc
Customers!
Website Created by Advanta Advertising LLC.
